drugset / Trial / NCT02683421
Evaluation of SC Injected Tc 99m Tilmanocept Localization in Active RA Subjects by SPECT and SPECT/CT Imaging
Non-randomizedSingle-groupOpen-labelDiagnostic
Summary
Determine the localization of Tc 99m tilmanocept by SPECT and SPECT/CT imaging in subjects with active RA and concordance with clinical symptomology.
Timeline
- Start
- 2016-07
- Primary completion
- 2016-12
- Completion
- 2016-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tilmanocept | Diagnostic / imaging agent | 50 ug | Subcutaneous |
| Subject | Tilmanocept | Diagnostic / imaging agent | 200 ug | Subcutaneous |